About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Carina Masferrer Ferragutcasas, Research technician, Biomedical Research in Gynaecology (VHIR) Carina Masferrer Ferragutcasas earned her degree in Biomedical Sciences from the University of Barcelona (UB) and a Master’s in Translational Biomedical Research from the Autonomous University of Barcelona (UAB) and VHIR, when she joined the group led by Dr. Eva Colás. As part of her PhD, last year she completed a research stay at the Novo Nordisk Foundation Center for Protein Research (NNF-CPR) and the University of Copenhagen, further expanding her expertise in advanced proteomics techniques.
Abstract: Endometriosis is a chronic, estrogen-dependent inflammatory disease that affects millions of women worldwide, often leading to pelvic pain and infertility. Current clinical staging does not correlate with clinical features of the disease, the pathophysiology of the condition is not well understood, and therapeutic options do not address the underlying causes of the disease. Up to 50% of patients experience lesion recurrence within five years of surgery, and there is no strategy to predict prognosis. Given the complexity and heterogeneity of the disease, advancing towards personalized medicine requires a deeper understanding of its molecular drivers.
Host: Dr. Eva Colas Ortega, Head of group, Biomedical Research in Gynaecology (VHIR)